NCM
CELG

Northstar Capital Management’s Celgene Corp CELG Stock Holding History

Northstar Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,055
Closed -$423K – 99
2017
Q4 		$423K Buy
+4,055
New +$458K 0.41% 37

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northstar Capital Management's CELG Position: Q1 2018 in Review

Northstar Capital Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 4,055 shares — an estimated $423K sold.

Northstar Capital Management first reported a position in CELG in Q4 2017 and held it in 1 quarter. The position peaked at $423K in Q4 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Northstar Capital Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Northstar Capital Management sold 4,055 Celgene Corp shares in Q1 2018, an estimated $423K.
  • Northstar Capital Management first reported a position in Celgene Corp in Q4 2017 and held it in 1 quarter.
  • Northstar Capital Management's Celgene Corp position peaked at $423K in Q4 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Northstar Capital Management's 13F filing for Q1 2018, filed 14 May 2018.